跳至主要内容
临床试验/NCT07099066
NCT07099066尚未招募不适用

Generation of Skin Fibroblast Banks, Urine-derived Cells and Biomarker Isolation From Patients With Amyotrophic Lateral Sclerosis (Als)

Human Cell Design0 个研究点目标入组 50 人开始时间: 2025年9月1日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
50
主要终点
Cell banking

研究概览

简要总结

The aim of this research is to establish different cell banks from patients with amyotrophic lateral sclerosis (ALS).

详细描述

The objective of this research is to:

  • Create banks of skin fibroblasts from skin biopsy samples
  • Create banks of urine-derived cells (UDCs) from urine samples
  • Build a collection of blood samples to enable isolation of biomarkers.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subjects over 18 years old;
  • Subjects who have given their consent and signed an informed, free and express consent form;
  • Subjects with diagnosed ALS;
  • Subjects affiliated to or benefiting from a social security scheme.

排除标准

  • Subjects with contraindications to the collection of biological samples (blood, skin, urine).
  • Subjects undergoing treatment likely to affect hemostasis (anticoagulants, platelet anti-aggregants, etc.) in the month prior to inclusion and during the study;
  • Subjects with hereditary or acquired haemostasis disorders;
  • Subjects who have undergone physical treatment (radiotherapy, etc.) on the area to be biopsied in the last 6 months;
  • Lidocaine-intolerant subjects;
  • Subjects who have reached the age of majority and are subject to a protective measure or are unable to express their consent.

结局指标

主要结局

Cell banking

时间窗: 8 months

Number of cell batches cryopreserved that meet predefined quality criteria (cell viability ≥ 80%, absence of mycoplasma). Data will be summarized as percentage of compliant batches over total batches produced.

次要结局

未报告次要终点

研究者

发起方
Human Cell Design
申办方类型
Industry
责任方
Sponsor

相似试验

Generation of Cell Banks and Biomarker Isolation... | 临床试验